Name: AirCurve 10 ST
Price: 3560.00 CAD
Availability: InStock

Description

The ResMed AirCurve 10 ST is a bilevel positive airway pressure machine with backup rate to provide exceptional patient–ventilator synchrony while reducing the work of breathing so you can remain comfortable and well-ventilated. It is a cost-effective and reliable device for patients requiring non-invasive ventilation when alarms are not required.

Adjustable trigger sensitivity supports patients with a weak inspiratory effort and the adjustable cycle is crucial for those at risk for intrinsic PEEP or premature breath cycling. The AirCurve 10 ST has a total of four operational modes – spontaneous (S), spontaneous/timed (S/T), timed (T), and conventional CPAP mode.

Features:

Easy-Breathe technology that copies the wave shape of the patient’s normal breathing and replicates it to deliver natural breathing comfort
Patient-ventilator synchronization – Vsync™ and TiControl™ features provide patient-ventilator synchrony, ensuring timely intervention during challenging conditions or leak
Optimal climate control – HumidAir™ humidifier and the ClimateLineAir™ heated air tube provide optimal climate control by delivering constant, comfortable temperature and humidity levels
myAir™ – this easy-to-use online support program and app that is available exclusively for Air10™ users, syncs up with your machine to let you know how you slept the night before, and helps you stay on track
with your sleep apnea treatment

Included:

Device
Humidifier
Water tank
Air tubing
Power supply unit
Travel bag
SD card (already inserted)
Manuals

Brand

ResMed

ResMed is a pioneer in sleep apnea treatment options. Established in 1989, ResMed has grown into a global leader in developing, manufacturing and distributing innovative medical devices such as CPAP machines and masks, as well as CPAP software solutions to better diagnose, treat, and manage sleep apnea, COPD and other respiratory diseases. In 2017, ResMed became an S&P 500 company with its annual revenues exceeding $2 billion. To date, ResMed operates in more than 120 countries and employs over 6,000 worldwide. Their mission is to change 20 million lives by 2020.